
Lapatinib (Etibo) is a targeted anticancer medicine used to treat certain types of HER2-positive breast cancer. It belongs to a group of medicines called tyrosine kinase inhibitors and is generally prescribed in combination with other cancer treatments. It works by blocking signals that help cancer cells grow and multiply.
| Generic Name | Lapatinib |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Packing | 30 Tablets |
| Prescribed For | HER2-positive breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Lapatinib blocks two proteins called HER2 and EGFR, which are involved in sending growth signals to cells. By inhibiting these proteins, it interferes with the signals that encourage certain breast cancer cells to grow and divide.